Search research articles
Contact Us
Filters
Showing results (111-120 of 145) with videos related to
Page
of 15
Sort By:
Blood Advances
|
April 6, 2019
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML
Renato Bassan, Tamara Intermesoli, Arianna Masciulli, et al.
Annals of Hematology
|
February 8, 2018
Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL)
Roberta Di Blasi, Chiara Cattaneo, Russell E Lewis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey
Corrado Girmenia, Alice Bertaina, Alfonso Piciocchi, et al.
The Journal of Antimicrobial Chemotherapy
|
December 16, 2020
Do high MICs predict the outcome in invasive fusariosis?
Marcio Nucci, Jeffrey Jenks, George R Thompson, et al.
Mycoses
|
October 25, 2021
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B survey
Maria Ilaria Del Principe, Giulia Dragonetti, Allegra Conti, et al.
Annals of Hematology
|
May 24, 2025
Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study
Luana Fianchi, Alfonso Piciocchi, Fabio Guolo, et al.
Blood
|
June 2, 2021
Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited antitumor activity
Antonio Sacco, Cinzia Federico, Katia Todoerti, et al.
Haematologica
|
August 29, 2020
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06
Chiara Caprioli, Federico Lussana, Silvia Salmoiraghi, et al.
Haematologica
|
May 30, 2020
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913
Sabina Chiaretti, Monica Messina, Irene Della Starza, et al.
Blood Advances
|
March 6, 2025
Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non-low-risk AML
Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 145) with videos related to
Sort By:
Page
of 15
Blood Advances
|
April 6, 2019
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML
Renato Bassan, Tamara Intermesoli, Arianna Masciulli, et al.
Annals of Hematology
|
February 8, 2018
Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL)
Roberta Di Blasi, Chiara Cattaneo, Russell E Lewis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey
Corrado Girmenia, Alice Bertaina, Alfonso Piciocchi, et al.
The Journal of Antimicrobial Chemotherapy
|
December 16, 2020
Do high MICs predict the outcome in invasive fusariosis?
Marcio Nucci, Jeffrey Jenks, George R Thompson, et al.
Mycoses
|
October 25, 2021
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B survey
Maria Ilaria Del Principe, Giulia Dragonetti, Allegra Conti, et al.
Annals of Hematology
|
May 24, 2025
Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study
Luana Fianchi, Alfonso Piciocchi, Fabio Guolo, et al.
Blood
|
June 2, 2021
Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited antitumor activity
Antonio Sacco, Cinzia Federico, Katia Todoerti, et al.
Haematologica
|
August 29, 2020
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06
Chiara Caprioli, Federico Lussana, Silvia Salmoiraghi, et al.
Haematologica
|
May 30, 2020
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913
Sabina Chiaretti, Monica Messina, Irene Della Starza, et al.
Blood Advances
|
March 6, 2025
Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non-low-risk AML
Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio, et al.
Page
of 15